Go Pro
→ Why major institutions are piling into this digital asset now (From Awesomely) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$46.82
+0.3%		$46.56
$42.20
▼
$109.50
$67.88B0.5619.52 million shs17.14 million shs
DexCom, Inc. stock logo
DXCM
DexCom
$90.82
+1.7%		$79.21
$54.11
▼
$92.59
$34.27B1.415.48 million shs2.55 million shs
Stryker Corporation stock logo
SYK
Stryker
$331.32
+2.9%		$329.10
$281.00
▼
$396.86
$126.84B0.762.35 million shs2.23 million shs
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
$171.16
-0.2%		$164.03
$133.73
▼
$176.60
$44.09B0.5611.65 million shs4.88 million shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.00%-7.08%+1.96%-3.10%-55.81%
DexCom, Inc. stock logo
DXCM
DexCom
0.00%-1.65%+21.84%+23.16%+18.91%
Stryker Corporation stock logo
SYK
Stryker
0.00%+0.44%-4.89%+8.37%-15.77%
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
0.00%-1.98%+4.67%+14.51%+24.96%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$46.82
+0.3%		$46.56
$42.20
▼
$109.50
$67.88B0.5619.52 million shs17.14 million shs
DexCom, Inc. stock logo
DXCM
DexCom
$90.82
+1.7%		$79.21
$54.11
▼
$92.59
$34.27B1.415.48 million shs2.55 million shs
Stryker Corporation stock logo
SYK
Stryker
$331.32
+2.9%		$329.10
$281.00
▼
$396.86
$126.84B0.762.35 million shs2.23 million shs
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
$171.16
-0.2%		$164.03
$133.73
▼
$176.60
$44.09B0.5611.65 million shs4.88 million shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.00%-7.08%+1.96%-3.10%-55.81%
DexCom, Inc. stock logo
DXCM
DexCom
0.00%-1.65%+21.84%+23.16%+18.91%
Stryker Corporation stock logo
SYK
Stryker
0.00%+0.44%-4.89%+8.37%-15.77%
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
0.00%-1.98%+4.67%+14.51%+24.96%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Boston Scientific Corporation stock logo
BSX
Boston Scientific
2.71
Moderate Buy$71.6252.96% Upside
DexCom, Inc. stock logo
DXCM
DexCom
2.89
Moderate Buy$88.71-2.33% Downside
Stryker Corporation stock logo
SYK
Stryker
2.79
Moderate Buy$386.2816.59% Upside
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
2.76
Moderate Buy$171.16N/A

Current Analyst Ratings Breakdown

Latest SYK, BSX, DXCM, and XLV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/25/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$56.00
8/13/2026
Stryker Corporation stock logo
SYK
Stryker
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
8/13/2026
Stryker Corporation stock logo
SYK
Stryker
Wolfe Research logo
Wolfe Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOutperform ➝ Peer Perform
8/11/2026
DexCom, Inc. stock logo
DXCM
DexCom
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C-) ➝ Hold (C)
8/4/2026
DexCom, Inc. stock logo
DXCM
DexCom
Argus logo
Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$86.00 ➝ $96.00
8/3/2026
Stryker Corporation stock logo
SYK
Stryker
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform
8/3/2026
DexCom, Inc. stock logo
DXCM
DexCom
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetBuy$82.00 ➝ $90.00
8/3/2026
Stryker Corporation stock logo
SYK
Stryker
Citizens Jmp logo
Citizens Jmp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetMarket Outperform$440.00 ➝ $400.00
7/31/2026
Stryker Corporation stock logo
SYK
Stryker
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
7/31/2026
DexCom, Inc. stock logo
DXCM
DexCom
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
7/31/2026
Stryker Corporation stock logo
SYK
Stryker
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOutperform$435.00 ➝ $420.00
(Data available from 8/30/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$20.07B3.38$4.03 per share11.61$17.37 per share2.70
DexCom, Inc. stock logo
DXCM
DexCom
$4.66B7.35$2.77 per share32.80$6.95 per share13.07
Stryker Corporation stock logo
SYK
Stryker
$25.12B5.06$16.92 per share19.58$62.54 per share5.30
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$2.90B$2.4718.9613.691.0217.50%19.28%10.89%10/28/2026 (Estimated)
DexCom, Inc. stock logo
DXCM
DexCom
$836.30M$2.5335.9029.491.5320.12%35.94%14.75%10/29/2026 (Estimated)
Stryker Corporation stock logo
SYK
Stryker
$3.25B$9.6534.3319.772.1114.43%23.63%11.39%10/29/2026 (Estimated)
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/AN/A21.15N/AN/AN/AN/AN/AN/A

Latest SYK, BSX, DXCM, and XLV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2026Q2 2026
DexCom, Inc. stock logo
DXCM
DexCom
$0.6110$0.70+$0.0890$0.64$1.29 billion$1.31 billion
7/30/2026Q2 2026
Stryker Corporation stock logo
SYK
Stryker
$3.49$3.69+$0.20$3.30$6.58 billion$6.59 billion
7/29/2026Q2 2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$0.83$0.86+$0.03$0.61$5.38 billion$5.44 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Boston Scientific Corporation stock logo
BSX
Boston Scientific
N/AN/AN/AN/AN/A
DexCom, Inc. stock logo
DXCM
DexCom
N/AN/AN/AN/AN/A
Stryker Corporation stock logo
SYK
Stryker
$3.521.06%+7.58%36.48%32 Years
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
$2.531.48%N/AN/AN/A

Latest SYK, BSX, DXCM, and XLV Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/4/2026
Stryker Corporation stock logo
SYK
Stryker
quarterly$0.881.04%9/30/20269/30/202610/30/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.43
1.24
0.74
DexCom, Inc. stock logo
DXCM
DexCom
0.47
1.73
1.43
Stryker Corporation stock logo
SYK
Stryker
0.59
2.16
1.33
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Boston Scientific Corporation stock logo
BSX
Boston Scientific
89.07%
DexCom, Inc. stock logo
DXCM
DexCom
97.75%
Stryker Corporation stock logo
SYK
Stryker
77.09%
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/A

Insider Ownership

CompanyInsider Ownership
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.34%
DexCom, Inc. stock logo
DXCM
DexCom
0.28%
Stryker Corporation stock logo
SYK
Stryker
4.60%
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Boston Scientific Corporation stock logo
BSX
Boston Scientific
59,0001.45 billion1.44 billionOptionable
DexCom, Inc. stock logo
DXCM
DexCom
11,000377.36 million376.30 millionOptionable
Stryker Corporation stock logo
SYK
Stryker
56,000383.57 million365.93 millionOptionable
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/A257.57 millionN/ANot Optionable

Recent News About These Companies

FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now
August 27 at 11:31 AM  |  zacks.comhttps://www.zacks.com/stock/news/2981072/fda-nods-lilly-roche-s-alzheimer-s-blood-test-healthcare-etfs-to-track-now?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2981072
Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)?
August 26, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2980096/should-you-invest-in-the-state-street-health-care-select-sector-spdr-etf-etf-xlv?cid=cs-stocknewsapi-ft-sector_etf-2980096
Healthcare Is Rising: XLV Is A Better Option For Investors Than BME
August 24, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4939451-healthcare-is-rising-xlv-is-a-better-option-for-investors-than-bme
Healthcare ETFs Are Looking Up: Here's Why
August 19, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2976778/healthcare-etfs-are-looking-up-here-s-why?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2976778
Likely ETF & Stock Winners From July Jobs Report
August 11, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2972555/likely-etf-stock-winners-from-july-jobs-report?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2972555
Sector ETFs Post Record $25B Inflow as Tech Leads
August 10, 2026  |  etftrends.comE
Vanguard Health Care ETF vs State Street XLV: Which ETF Is the Better Buy for Investors in 2026?
August 8, 2026  |  fool.comhttps://www.fool.com/coverage/etfs/2026/08/08/vanguard-health-care-etf-vs-state-street-xlv-which-etf-is-the-better-buy-for-investors-in-2026/
Broad Market Momentum & Defensive Pivots: This Week's Top ETF Flows
August 7, 2026  |  etftrends.comE
4 Healthcare Stocks to Watch as Defensive Demand Strengthens
August 7, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2970827/4-healthcare-stocks-to-watch-as-defensive-demand-strengthens?cid=cs-stocknewsapi-ft-analyst_blog|investment_ideas-2970827
State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026?
August 5, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/state-street-xlv-vs-vaneck-192201140.html
Showstopper Healthcare Earnings Elevate Use Case for XLV
August 5, 2026  |  etftrends.comE
Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in July 2026
August 3, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4623418-short-interest-alert-most-and-least-shorted-sub-2b-healthcare-stocks-in-july-2026
Which Is the Better State Street Healthcare ETF: The Broad XLV or the Biotech XBI?
August 3, 2026  |  fool.comhttps://www.fool.com/coverage/etfs/2026/08/03/which-is-the-better-state-street-healthcare-etf-the-broad-xlv-or-the-biotech-xbi/
XLV vs. IBBQ: Is Broad Healthcare Exposure or Biotech Growth the Better ETF Buy?
August 1, 2026  |  fool.comhttps://www.fool.com/coverage/etfs/2026/08/01/xlv-vs-ibbq-is-broad-healthcare-exposure-or-biotech-growth-the-better-etf-buy/
XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist?
August 1, 2026  |  fool.comhttps://www.fool.com/coverage/etfs/2026/08/01/xlv-vs-pbe-is-a-low-cost-healthcare-etf-the-better-buy-than-a-focused-biotech-specialist/
XLV vs. IHE: Which Healthcare ETF Is the Better Buy?
July 31, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/xlv-vs-ihe-healthcare-etf-161328828.html
Financial Sector ETF Hits Record High on Fintech Gains
July 28, 2026  |  etftrends.comE
UnitedHealth Pulls Back Post 52-Week High: Healthcare ETFs to Watch
July 27, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2961471/unitedhealth-pulls-back-post-52-week-high-healthcare-etfs-to-watch?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2961471
XLV vs FHLC: Which Healthcare ETF Fits Your Portfolio?
July 27, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/xlv-vs-fhlc-healthcare-etf-125501073.html
PINK vs. XLV: How Do These Two Health Care ETFs Match Up?
July 26, 2026  |  fool.comhttps://www.fool.com/coverage/etfs/2026/07/26/pink-vs-xlv-how-do-these-two-health-care-etfs-match-up/
These Stocks Could Be the Biggest Winners of the 2026 Midterms (XLV)
...
May 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/stock-ideas/these-stocks-could-be-the-biggest-winners-of-the-2026-midterms/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Boston Scientific stock logo

Boston Scientific NYSE:BSX

$46.82 +0.15 (+0.32%)
As of 08/28/2026 03:58 PM Eastern

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

DexCom stock logo

DexCom NASDAQ:DXCM

$90.82 +1.53 (+1.71%)
As of 08/28/2026 04:00 PM Eastern

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Stryker stock logo

Stryker NYSE:SYK

$331.32 +9.20 (+2.86%)
As of 08/28/2026 03:58 PM Eastern

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Health Care Select Sector SPDR Fund stock logo

Health Care Select Sector SPDR Fund NYSEARCA:XLV

$171.16 -0.42 (-0.24%)
As of 08/28/2026 04:10 PM Eastern

Health Care Select Sector SPDR Fund (the Fund) seeks to closely match the returns and characteristics of the S&P Health Care Select Sector Index (the Index). The companies included in the Index are selected on the basis of general industry classification from a universe of companies defined by the Standard & Poor's 500 Composite Stock Index (S&P 500). The Health Care Select Sector Index includes companies from the industries, such as pharmaceuticals, healthcare providers and services, healthcare equipment and supplies, biotechnology, life sciences tools and services, and healthcare technology. Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index. State Street Global Advisors acts as the Fund's investment manager.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas